• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Build on Bitcoin Expands to Multichain with ICP Launch

chest

Build on Bitcoin has launched on the Internet Computer (ICP), securing over 7,000 wallets and aiming to become a DeFi hub for Bitcoin.

user avatarRajesh Kumar

Global Fintech and Crypto Regulations Tighten

chest

The global regulatory landscape for fintech and crypto is becoming increasingly stringent, impacting businesses operating across borders.

user avatarFilippo Romano

Upcoming Trends in Crypto Regulations

chest

Ivan Nevzorov predicts key regulatory trends in the crypto space for the coming years, including stablecoins and Real World Assets.

user avatarLucas Weissmann

Cayman Islands to Implement New Crypto Reporting Framework in 2026

chest

The Cayman Islands is set to implement the CryptoAsset Reporting Framework (CARF) in 2026, affecting crypto service providers.

user avatarTomas Novak

Cayman Islands Foundation Company Registrations Surge Amid Web3 Growth

chest

Cayman Islands experiences a 70% increase in foundation company registrations, driven by DAOs and Web3 growth.

user avatarEmily Carter

Kalshi's Tokenization Strategy Enhances Trading Experience

chest

Kalshi's tokenization strategy enhances trading experience by enabling faster transactions and anonymous trading, integrating with DeFi protocols.

user avatarLeo van der Veen

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.